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Male breast cancer is an uncommon disease that has been the focus 
of limited researches. Its etiology is unclear, but hormonal levels 
may play a role in the development of this disease. Our case is a 84 
year old patient treated for breast cancer 12 years ago, it was an 
infiltrating ductal carcinoma classified pT2 N0 M0 with hormone 
receptor positive (HR +), treated with surgery, adjuvant 
chemotherapy, radiation therapy and 5 years of endocrinotherapy 
(tamoxifen 20mg 1 tablet daily continuously). Clinical control of our 
patient was normal within 11 years and 10 months. A month ago, 
the patient had headache and vomiting complicated by the sudden 
onset of left hemiplegia. The brain MRI showed a huge right 
temporal process with a shift of the midline structures (figure). A 
biopsy was also performed and demonstrated a cerebral relapsed 
breast primitive with the same disease profile (HR positive and 
HER2 negative). Brain metastases traditionally occur in 10-16% of 
metastatic breast cancer patients and are associated with a bad 
prognosis. The development of brain metastases has been 
associated with young age, and tumors that are estrogen receptor 
negative, HER2 positive or of the basal phenotype. However, we 
can also have brain metastases of a primary breast cancer in elderly 
patients even with pathological and immunohistochemistry different 
profiles regardless of gender.  
 
 
Figure 1: brain MRI (axial section, 
injected T1-weighted sequence) showing 
a huge right temporal mass, taking 
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